[CrossRef] [Google Scholar] Microneedling therapy in atrophic facial scars: An objective assessment
The anti-inflammatory pathways modulated by GLP-1 receptor activation (NF-kB suppression, macrophage polarization, Treg enhancement) are largely distinct from the pathways targeted by: Methotrexate: Folate metabolism disruption, different anti-inflammatory pathway TNF inhibitors (adalimumab, etanercept): Direct TNF blockade, whereas GLP-1 reduces TNF production upstream IL-6 inhibitors (tocilizumab): Receptor-level blockade, while GLP-1 reduces IL-6 production JAK inhibitors (tofacitinib, baricitinib): Different signaling pathway entirely Corticosteroids: Broad immunosuppression, while GLP-1 is immunomodulatory This pathway complementarity is why additive benefit is biologically plausible
Sami M, Rashid A, Akram M, Ibadi AK, Mbaye EH, Sami M, et al
Combining them in one preparation is what makes the blend a convenient reference system for in vitro work that needs both activities in a single run
Real factory, support all kinds of factory inspection